Clark Capital Management Group’s Quest Diagnostics DGX Stock Holding History

Clark Capital Management Group’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$46.1M	Buy	+235,422	New	+$45.7M	0.28%	113
2023 Q4	–	Sell	-5,960	Closed	-$726K	–	376
2023 Q3	$726K	Buy	5,960 +9	+0.2%	+$1.2K	0.01%	270
2023 Q2	$836K	Buy	5,951 +1,526	+34%	+$210K	0.01%	263
2023 Q1	$626K	Buy	+4,425	New	+$633K	0.01%	273
2017 Q4	–	Sell	-301,785	Closed	-$28.3M	–	282
2017 Q3	$28.3M	Sell	301,785 -54,900	-15%	-$5.83M	0.95%	25
2017 Q2	$39.6M	Buy	356,685 +112,985	+46%	+$11.9M	1.54%	7
2017 Q1	$23.9M	Buy	+243,700	New	+$23.2M	1.06%	25
2015 Q3	–	Sell	-2,848	Closed	-$207K	–	312
2015 Q2	$207K	Sell	2,848 -95,455	-97%	-$7.05M	0.02%	311
2015 Q1	$7.55M	Buy	+98,303	New	+$7.04M	0.69%	50

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Clark Capital Management Group's DGX Position: Q1 2026 in Review

Clark Capital Management Group opened a new position in Quest Diagnostics (DGX) in Q1 2026: 235,422 shares worth $46.1M. The stake represents 0.28% of the portfolio and ranks #113 among its holdings. This is a return to the name: Clark Capital Management Group previously reported a position in DGX as recently as Q3 2023.

Clark Capital Management Group first reported a position in DGX in Q1 2015 and has held it in 9 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Clark Capital Management Group held 235,422 shares of Quest Diagnostics worth $46.1M as of Q1 2026.
Quest Diagnostics was a new Clark Capital Management Group position in Q1 2026.
Quest Diagnostics made up 0.28% of Clark Capital Management Group's portfolio in Q1 2026, its #113 holding.
Clark Capital Management Group first reported a position in Quest Diagnostics in Q1 2015 and has held it in 9 quarters since.
1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Clark Capital Management Group's 13F filing for Q1 2026, filed 15 May 2026.